NCT05157854 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Eklund M, Argentzell E, Bejerholm U, Tjornstrand C, Brunt D
Wellbeing, activity and housing satisfaction - comparing residents with psychiatric disabilities in supported housing and ordinary housing with support. BMC Psychiatry. 2017 Aug 30;17(1):315. doi: 10.1186/s12888-017-1472-2.
Tjornstrand C, Eklund M, Bejerholm U, Argentzell E, Brunt D
A day in the life of people with severe mental illness living in supported housing. BMC Psychiatry. 2020 Oct 15;20(1):508. doi: 10.1186/s12888-020-02896-3.

Development and Process Evaluation of an Activity- and Recovery-oriented Intervention for People With Severe Mental Illness Living in Supported Housing - Active in My Home (AiMH)

Details for clinical trial NCT05157854

Clinical trial NCT05157854 - References